41 – 50 of 53
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis
(
- Contribution to journal › Article
-
Mark
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray"
(
- Contribution to journal › Scientific review
-
Mark
Biphenotypic bigenotypic lymphoma with simultaneous expression of PAX5/BSAP and B- and T-cell markers
(
- Contribution to journal › Article
-
Mark
Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread
(
- Contribution to journal › Article
-
Mark
Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: Higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN
(
- Contribution to journal › Article
-
Mark
Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals
(
- Contribution to journal › Article
- 2006
-
Mark
Autoimmune diseases, asthma and risk of haematological malignancies: A nationwide case-control study in Sweden
(
- Contribution to journal › Article
- 2005
-
Mark
Core-needle biopsy performed by the cytopathologist : a technique to complement fine-needle aspiration of soft tissue and bone lesions
(
- Contribution to journal › Article
-
Mark
Radioimmunoterapi ved non-Hodgkins lymfom
(
- Contribution to journal › Article
-
Mark
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis
(
- Contribution to journal › Article